Full view

Medication language     Source https://www.rxlist.com/creon-drug.htm
LASTREVIEWED 18.10.2016

Brand Name Creon
Generic Name Pancrelipase


Distributer AbbVie Inc., North Chicago, IL 60064, U.S.A. Revised:September, 2012
    Pharmacotherapeutic group     Description     Pharmacokinetics     Clinical Pharmacology     Indications     ContraIndications     Warnings     Precautions     Side effects     Dosage and administration     Overdosage     Drug interactions     Patient Information     How Supplied     Storage conditions And Handling

Description

CREON is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands.Pancrelipase contains multiple enzyme classes, including porcine-derived lipases, proteases, and amylases.
Pancrelipase is a beige-white amorphous powder.It is miscible in water and practically insoluble or insoluble in alcohol and ether.
Each delayed-release capsule for oral administration contains enteric-coated spheres (0.71-1.60 mm in diameter).
The active ingredient evaluated in clinical trials is lipase.CREON is dosed by lipase units.
Other active ingredients include protease and amylase.
CREON contains the following inactive ingredients: cetyl alcohol, dimethicone, hypromellose phthalate, polyethylene glycol, and triethyl citrate.
3,000 USP units of lipase; 9,500 USP units of protease;15,000 USP units of amylase delayed-release capsules have a white opaque cap with imprint “CREON 1203”and a white opaque body.The shells contain titanium dioxide and hypromellose.
6,000 USP units of lipase; 19,000 USP units of protease;30,000 USP units of amylase delayed-release capsules have a Swedish-orange opaque cap with imprint “CREON 1206”and a blue opaque body.The shells contain FD&C Blue No.2, gelatin, red iron oxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
12,000 USP units of lipase; 38,000 USP units of protease;60,000 USP units of amylase delayed-release capsules have a brown opaque cap with imprint “CREON 1212”and a colorless transparent body.The shells contain black iron oxide, gelatin, red iron oxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
24,000 USP units of lipase; 76,000 USP units of protease;120,000 USP units of amylase delayed-release capsules have a Swedish-orange opaque cap with imprint “CREON 1224”and a colorless transparent body.The shells contain gelatin, red iron oxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
36,000 USP units of lipase; 114,000 USP units of protease;180,000 USP units of amylase delayed-release capsules have a blue opaque cap with imprint “CREON 1236”and a colorless transparent body.The shells contain gelatin, titanium dioxide, FD&C Blue No.2 and sodium lauryl sulfate.


Sale proviso
Errors found - 0

Analogs

MarkLanguageBrand NameGeneric NamePharmacotherapeutic groupRelease forms
ENGLISH (english)Creon 10pancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)Creon 20pancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)Creon 5pancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)PancrecarbpancrelipasePancreatic enzymes. Treatment of exocrine pancreatic enzyme insufficiencyTablets
ENGLISH (english)PertzyepancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)UltrasepancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)Ultrase MTpancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)UltresapancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)ViokacepancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
ENGLISH (english)ViokasepancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets, Powder
ENGLISH (english)ZenpeppancrelipasePancreatic enzymes. Treatment of exocrine pancreatic insufficiencyTablets
11 Medications
         
Medication Analogs Generic Name medicines of the ATC group

PharmHint - Start page
PharmHint - Medications select page